Virtu Financial LLC Xenon Pharmaceuticals Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024
BUY
$42.66 - $50.04 $284,158 - $333,316
6,661 New
6,661 $287,000
Q2 2023

Jul 27, 2023
BUY
$34.84 - $43.54 $232,800 - $290,934
6,682 New
6,682 $257,000
Q4 2022

Feb 15, 2023
BUY
$33.06 - $39.43 $185,268 - $220,965
5,604 New
5,604 $221,000
Q1 2019

Apr 12, 2019
SELL
$6.39 - $10.42 $81,127 - $132,292
-12,696 Closed
0 $0
Q4 2018

Jan 16, 2019
BUY
$5.61 - $12.62 $71,224 - $160,223
12,696 New
12,696 $80,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email